Theralase Technologies Inc. (TLT.V)
Develops light-activated cancer drugs and laser therapy devices for treating tumors and infections.
0.27+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+22.7%
The outlook
TLT.V is trading above both its 50- and 200-day moving averages, positioning it in the middle of its 52-week range. Analyst coverage shows an average price target roughly 159% above the current price, though coverage appears limited. The overall data leans bullish at 77/100.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range46% of the way from its 52-week low to high
Price targetAvg target +159% vs current price
Market cap
$79.8M
52-wk high
0.41
52-wk low
0.15
50-day avg
0.25
200-day avg
0.24
Trailing P/E
—